NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
NHS EnglandcontractFind a Tender ↗Ref ocds-h6vhtk-051c98Procurement Act 2023SME suitableclosed for bids
Estimated value
£877.7m
goods
Awarded value
—
Suppliers
0
Lots
2
0 awarded
Published
17 Mar 2026
Deadline 17 Apr 2026
Description
NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months. Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
Scope
- Reference
- C414060
- Total value
- £877,670,570 excluding VAT£1,053,204,684 including VATAbove the relevant threshold
- Commercial tool
- Standalone contract
- Contract dates
- 31 Aug 2026 to 31 Aug 2028Possible extension to 31 Aug 2030
With an option or option(s) to extend for a further 24 months.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- North East England, United KingdomNorth West England, United KingdomEast Midlands, United KingdomWest Midlands, United KingdomEast of England, United KingdomLondon, United KingdomSouth East England, United KingdomSouth West England, United Kingdom
- Particular suitability
- Small and medium-sized enterprises (SME)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Price is not the only award criterion | Price is not the only award criterion and all criteria are stated only in the procurement documents | price | — |
Submission & procedure
- Enquiry deadline
- 10 Apr 2026, 4:00 pm
- Submission deadline
- 17 Apr 2026, 12:00 pm
- Submission address
- The procurement documents are available for unrestricted and full direct access, free of charge at https://health-family.force.com/s/Welcome Additional info obtained from the abovementioned address. Tenders must be submitted to the abovementioned address
- Electronic submission
- Yes
- Procedure
- Open procedure
Lots · 2 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | £846.1m | active |
| 2 | CM/PHR/25/5730/02 - Natalizumab for London & SOFE | £31.5m | active |